Emma Andrus, Associate Editor

UCB presented data from the BE HEARD I and BE HEARD II phase 3 studies at this year's EADV Congress.

Almirall presented new data on lebrikizumab at EADV related to clinical improvements and clinically-meaningful treatment responses among patients with atopic dermatitis.

Last week was Body-Focused Repetitive Behaviors Awareness Week. Related to dermatology, dermatillomania, also known as skin picking disorder, is a condition that requires empathy and understanding year round.

Patients and their families experienced significant improvements to well-being with tildrakizumab use in as little as 16 weeks.

A European Academy of Dermatology and Venereology study explored the pathway from dermatologic consult to diagnosis to treatment and outcomes in the health care system.

Dermatologist Diego Ruiz Dasilva, MD, FAAD, and a patient with atopic dermatitis discuss the patient journey from initial symptoms to diagnosis to treatment selection.

This World Mental Health Day, Dermatology Times is reviewing the important and often comorbid mental health concerns linked to common dermatologic conditions.

The grant will go toward supporting the group's project, "Atopic Dermatitis is More Than a Skin Disease: Raising Awareness and Improving Care."

Protagonist Therapeutics has just announced the company's eligibility to receive $60 million of milestone payments for JNJ-2113 to enter into clinical development programs led by Janssen.

In this expert Q&A, dermatologist Jeffrey Cizenski, MD, FAAD, offers perspectives on National Eczema Awareness Month and AbbVie's Under My Skin documentary.

Keep up with the latest headlines in dermatology from the past week, including an accessible dermatology clinic for under or uninsured patients, a groundbreaking 3D bioprinting technique to create near-perfect human skin grafts for wound healing, and more.

Amy Spizuoco, DO, FAOCD, shares her atopic dermatitis insights.

Dermatology physician assistant Renata Block, MMS, PA-C, discusses pearls and best practices for patients ahead of October and Halloween festivities.

Greg Pierce of Synchrony discusses CareCredit's Path to Care study and its findings related to cost and finance considerations for cosmetic dermatology patients.

This Body-Focused Repetitive Behaviors Awareness Week, Dermatology Times is spotlighting the role of the only donor-supported nonprofit organization for dermatillomania in spreading awareness and education of skin picking.

Colleen Cotton, MD, discusses the treatment landscape of pediatric atopic dermatitis, highlights from her session at Maui Derm NP+PA in Asheville, NC, and more.

The designation now applies to all approved indications, which includes dermatologic conditions such as psoriatic arthritis, plaque psoriasis, and hidradenitis suppurativa.

A real-world retrospective analysis also found that among patients receiving treatment, most were unlikely to use more than 1 treatment or switch to an alternative treatment during the first year of diagnosis.

Many studies have investigated the associations between lichen sclerosus and vulvar and penile SCCs, as well as genital melanomas.

Investigators evaluated the most important markers associated with the pathogenesis of vitiligo, including serum inflammatory and oxidative stress markers.

In a cohort of patients in the UK, investigators found that SARS-CoV-2 was associated with increased incidence of several immune-mediated inflammatory diseases, with psoriasis among them.